Tag: genomics services industry share

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Genomics Services Market Expansion From $21.56 Billion In 2026 To $37.78 Billion In 2030

Within the genomics services sector, a significant upswing in market value has been observed, with projections indicating continued robust expansion; specifically, the market is anticipated to ascend from $18.29 billion in 2025 to $21.56 billion in 2026, representing a compound annual growth rate of 17.9%. This preceding growth trajectory was notably influenced by factors such as the initial willingness of academic and research bodies to integrate these technologies, the increasing commercial availability of sequencing services, the burgeoning research activities within the biopharmaceutical industry, a growing pool of proficient bioinformaticians, and the extended reach of laboratory services.

The genomics services sector anticipates substantial expansion over the coming years, projecting a market valuation of $37.78 billion by 2030, fueled by a compound annual growth rate of 15.0%. This upward trajectory is largely a consequence of the increasing incorporation of genomics into standard medical practices, a rising interest in preventative genomic approaches, the expanding utility of companion diagnostics, the seamless integration with digital health solutions, and a burgeoning ecosystem of genomics-focused startups. Furthermore, the forecast period is characterized by several prominent trends, including a heightened demand for both sequencing and interpretation of genomic data, the broader adoption of personalized genomic health services, a greater reliance on outsourced genomic analysis, the accelerated uptake of clinical genomics services, and the proliferation of large-scale population genomics initiatives.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15576&type=smp

Genomics Services Market Growth Drivers And Industry Catalysts

The expansion of the genomics services market is anticipated to be significantly boosted by the escalating need for gene therapy. Gene therapy, a revolutionary medical approach, aims to combat or avert illnesses by directly tackling the root genetic cause. It offers precisely aimed interventions for inherited conditions and long-term ailments by confronting their underlying genetic origins. Within the realm of gene therapy, genomic services play a crucial role, aiding in identifying the appropriate target tissues, precisely measuring and describing viral vectors, and discerning the potential risk of virus shedding. Illustrating this connection, data from April 2024, as published by the U.S. Food and Drug Administration (FDA), a governmental oversight body in the United States, indicated that a genetic cause has been identified for over 80% of rare diseases. The FDA has since authorized 22 gene therapy products, with the majority designated for the treatment of rare conditions, underscoring how the rising demand for gene therapy is stimulating the growth of the genomics services sector.

Genomics Services Market Segment Landscape And Growth Potential

The genomics services market covered in this report is segmented –

1) By Product: Instruments Or Systems Or Software, Consumables And Reagents

2) By Services Type: Gene Expression Services (RNASeq), Epigenomics Services, Genotyping, Next-Generation Sequencing, Sanger Sequencing, Other Service Types

3) By End-User: Research Institutes, Healthcare Facilities And Diagnostic Centers, Pharmaceutical And Biotechnological Companies, Contract Research Organizations (CROs), Other End Users

Subsegments:

1) By Instruments Or Systems Or Software: Sequencing Instruments and Platforms, Bioinformatics and Genomic Data Analysis Software

2) By Consumables And Reagents: Library Preparation Kits and Sample Preparation Reagents, Sequencing Reagents and Flow Cells

#Genomics Services Market Trends Influencing Long-Term Demand

Leading players in the genomics services sector are concentrating on broadening their service offerings, incorporating sophisticated solutions like advanced long-read sequencing to address the escalating need for in-depth genomic examination and tailored medical treatments. These advanced long-read sequencing capabilities leverage state-of-the-art methodologies for analyzing genetic material, producing longer sequence reads that enable a more complete and precise depiction of DNA and RNA. As an illustration, in April of 2024, the biotechnology firm Clinical-Microbiomics A/S, based in Denmark, introduced its advanced long-read sequencing services, which encompass a suite of options including 16S, ITS, 18S rRNA, isolate, and metagenomics sequencing. These thoughtfully designed services are specifically developed to satisfy the rigorous demands of scholars, clinicians, and industry professionals, delivering exceptional clarity and high standards in the examination of microbes. By offering a diverse array of sequencing choices, these enhanced long-read technologies are poised to set new benchmarks for microbial analysis and the study of microbiomes, offering researchers profound understanding of microbial ecosystems and paving the way for pioneering breakthroughs.

Genomics Services Market Competitive Landscape: Who Are The Leading Companies?

Major companies operating in the genomics services market are Thermo Fisher Scientific Inc., Danaher Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., QIAGEN Inc., LGC Limited, Myriad Genetics Inc., Q2 Solutions Inc., BGI Genomics Inc., 10x Genomics Inc., Invitae Corporation, Fulgent Genetics Inc., 23andMe Inc., Oxford Nanopore Technologies plc, Color Genomics Inc., GENEWIZ Inc., Foundation Medicine Inc., Pacific Biosciences Inc., Avance Biosciences Inc., Macrogen Inc

Access The Complete Genomics Services Market Report:

https://www.thebusinessresearchcompany.com/report/genomics-services-global-market-report

Genomics Services Market Regional Analysis And Leading Geography

North Americawas the largest region in the genomics services market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the genomics services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Genomics Services Market Expansion From $21.56 Billion In 2026 To $37.78 Billion In 2030

Within the genomics services sector, a significant upswing in market value has been observed, with projections indicating continued robust expansion; specifically, the market is anticipated to ascend from $18.29 billion in 2025 to $21.56 billion in 2026, representing a compound annual growth rate of 17.9%. This preceding growth trajectory was notably influenced by factors such as the initial willingness of academic and research bodies to integrate these technologies, the increasing commercial availability of sequencing services, the burgeoning research activities within the biopharmaceutical industry, a growing pool of proficient bioinformaticians, and the extended reach of laboratory services.

The genomics services sector anticipates substantial expansion over the coming years, projecting a market valuation of $37.78 billion by 2030, fueled by a compound annual growth rate of 15.0%. This upward trajectory is largely a consequence of the increasing incorporation of genomics into standard medical practices, a rising interest in preventative genomic approaches, the expanding utility of companion diagnostics, the seamless integration with digital health solutions, and a burgeoning ecosystem of genomics-focused startups. Furthermore, the forecast period is characterized by several prominent trends, including a heightened demand for both sequencing and interpretation of genomic data, the broader adoption of personalized genomic health services, a greater reliance on outsourced genomic analysis, the accelerated uptake of clinical genomics services, and the proliferation of large-scale population genomics initiatives.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15576&type=smp

Genomics Services Market Growth Drivers And Industry Catalysts

The expansion of the genomics services market is anticipated to be significantly boosted by the escalating need for gene therapy. Gene therapy, a revolutionary medical approach, aims to combat or avert illnesses by directly tackling the root genetic cause. It offers precisely aimed interventions for inherited conditions and long-term ailments by confronting their underlying genetic origins. Within the realm of gene therapy, genomic services play a crucial role, aiding in identifying the appropriate target tissues, precisely measuring and describing viral vectors, and discerning the potential risk of virus shedding. Illustrating this connection, data from April 2024, as published by the U.S. Food and Drug Administration (FDA), a governmental oversight body in the United States, indicated that a genetic cause has been identified for over 80% of rare diseases. The FDA has since authorized 22 gene therapy products, with the majority designated for the treatment of rare conditions, underscoring how the rising demand for gene therapy is stimulating the growth of the genomics services sector.

Genomics Services Market Segment Landscape And Growth Potential

The genomics services market covered in this report is segmented –

1) By Product: Instruments Or Systems Or Software, Consumables And Reagents

2) By Services Type: Gene Expression Services (RNASeq), Epigenomics Services, Genotyping, Next-Generation Sequencing, Sanger Sequencing, Other Service Types

3) By End-User: Research Institutes, Healthcare Facilities And Diagnostic Centers, Pharmaceutical And Biotechnological Companies, Contract Research Organizations (CROs), Other End Users

Subsegments:

1) By Instruments Or Systems Or Software: Sequencing Instruments and Platforms, Bioinformatics and Genomic Data Analysis Software

2) By Consumables And Reagents: Library Preparation Kits and Sample Preparation Reagents, Sequencing Reagents and Flow Cells

#Genomics Services Market Trends Influencing Long-Term Demand

Leading players in the genomics services sector are concentrating on broadening their service offerings, incorporating sophisticated solutions like advanced long-read sequencing to address the escalating need for in-depth genomic examination and tailored medical treatments. These advanced long-read sequencing capabilities leverage state-of-the-art methodologies for analyzing genetic material, producing longer sequence reads that enable a more complete and precise depiction of DNA and RNA. As an illustration, in April of 2024, the biotechnology firm Clinical-Microbiomics A/S, based in Denmark, introduced its advanced long-read sequencing services, which encompass a suite of options including 16S, ITS, 18S rRNA, isolate, and metagenomics sequencing. These thoughtfully designed services are specifically developed to satisfy the rigorous demands of scholars, clinicians, and industry professionals, delivering exceptional clarity and high standards in the examination of microbes. By offering a diverse array of sequencing choices, these enhanced long-read technologies are poised to set new benchmarks for microbial analysis and the study of microbiomes, offering researchers profound understanding of microbial ecosystems and paving the way for pioneering breakthroughs.

Genomics Services Market Competitive Landscape: Who Are The Leading Companies?

Major companies operating in the genomics services market are Thermo Fisher Scientific Inc., Danaher Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., QIAGEN Inc., LGC Limited, Myriad Genetics Inc., Q2 Solutions Inc., BGI Genomics Inc., 10x Genomics Inc., Invitae Corporation, Fulgent Genetics Inc., 23andMe Inc., Oxford Nanopore Technologies plc, Color Genomics Inc., GENEWIZ Inc., Foundation Medicine Inc., Pacific Biosciences Inc., Avance Biosciences Inc., Macrogen Inc

Access The Complete Genomics Services Market Report:

https://www.thebusinessresearchcompany.com/report/genomics-services-global-market-report

Genomics Services Market Regional Analysis And Leading Geography

North Americawas the largest region in the genomics services market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the genomics services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Genomics Services Market Expansion From $21.56 Billion In 2026 To $37.78 Billion In 2030

Within the genomics services sector, a significant upswing in market value has been observed, with projections indicating continued robust expansion; specifically, the market is anticipated to ascend from $18.29 billion in 2025 to $21.56 billion in 2026, representing a compound annual growth rate of 17.9%. This preceding growth trajectory was notably influenced by factors such as the initial willingness of academic and research bodies to integrate these technologies, the increasing commercial availability of sequencing services, the burgeoning research activities within the biopharmaceutical industry, a growing pool of proficient bioinformaticians, and the extended reach of laboratory services.

The genomics services sector anticipates substantial expansion over the coming years, projecting a market valuation of $37.78 billion by 2030, fueled by a compound annual growth rate of 15.0%. This upward trajectory is largely a consequence of the increasing incorporation of genomics into standard medical practices, a rising interest in preventative genomic approaches, the expanding utility of companion diagnostics, the seamless integration with digital health solutions, and a burgeoning ecosystem of genomics-focused startups. Furthermore, the forecast period is characterized by several prominent trends, including a heightened demand for both sequencing and interpretation of genomic data, the broader adoption of personalized genomic health services, a greater reliance on outsourced genomic analysis, the accelerated uptake of clinical genomics services, and the proliferation of large-scale population genomics initiatives.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15576&type=smp

Genomics Services Market Growth Drivers And Industry Catalysts

The expansion of the genomics services market is anticipated to be significantly boosted by the escalating need for gene therapy. Gene therapy, a revolutionary medical approach, aims to combat or avert illnesses by directly tackling the root genetic cause. It offers precisely aimed interventions for inherited conditions and long-term ailments by confronting their underlying genetic origins. Within the realm of gene therapy, genomic services play a crucial role, aiding in identifying the appropriate target tissues, precisely measuring and describing viral vectors, and discerning the potential risk of virus shedding. Illustrating this connection, data from April 2024, as published by the U.S. Food and Drug Administration (FDA), a governmental oversight body in the United States, indicated that a genetic cause has been identified for over 80% of rare diseases. The FDA has since authorized 22 gene therapy products, with the majority designated for the treatment of rare conditions, underscoring how the rising demand for gene therapy is stimulating the growth of the genomics services sector.

Genomics Services Market Segment Landscape And Growth Potential

The genomics services market covered in this report is segmented –

1) By Product: Instruments Or Systems Or Software, Consumables And Reagents

2) By Services Type: Gene Expression Services (RNASeq), Epigenomics Services, Genotyping, Next-Generation Sequencing, Sanger Sequencing, Other Service Types

3) By End-User: Research Institutes, Healthcare Facilities And Diagnostic Centers, Pharmaceutical And Biotechnological Companies, Contract Research Organizations (CROs), Other End Users

Subsegments:

1) By Instruments Or Systems Or Software: Sequencing Instruments and Platforms, Bioinformatics and Genomic Data Analysis Software

2) By Consumables And Reagents: Library Preparation Kits and Sample Preparation Reagents, Sequencing Reagents and Flow Cells

#Genomics Services Market Trends Influencing Long-Term Demand

Leading players in the genomics services sector are concentrating on broadening their service offerings, incorporating sophisticated solutions like advanced long-read sequencing to address the escalating need for in-depth genomic examination and tailored medical treatments. These advanced long-read sequencing capabilities leverage state-of-the-art methodologies for analyzing genetic material, producing longer sequence reads that enable a more complete and precise depiction of DNA and RNA. As an illustration, in April of 2024, the biotechnology firm Clinical-Microbiomics A/S, based in Denmark, introduced its advanced long-read sequencing services, which encompass a suite of options including 16S, ITS, 18S rRNA, isolate, and metagenomics sequencing. These thoughtfully designed services are specifically developed to satisfy the rigorous demands of scholars, clinicians, and industry professionals, delivering exceptional clarity and high standards in the examination of microbes. By offering a diverse array of sequencing choices, these enhanced long-read technologies are poised to set new benchmarks for microbial analysis and the study of microbiomes, offering researchers profound understanding of microbial ecosystems and paving the way for pioneering breakthroughs.

Genomics Services Market Competitive Landscape: Who Are The Leading Companies?

Major companies operating in the genomics services market are Thermo Fisher Scientific Inc., Danaher Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., QIAGEN Inc., LGC Limited, Myriad Genetics Inc., Q2 Solutions Inc., BGI Genomics Inc., 10x Genomics Inc., Invitae Corporation, Fulgent Genetics Inc., 23andMe Inc., Oxford Nanopore Technologies plc, Color Genomics Inc., GENEWIZ Inc., Foundation Medicine Inc., Pacific Biosciences Inc., Avance Biosciences Inc., Macrogen Inc

Access The Complete Genomics Services Market Report:

https://www.thebusinessresearchcompany.com/report/genomics-services-global-market-report

Genomics Services Market Regional Analysis And Leading Geography

North Americawas the largest region in the genomics services market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the genomics services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Will The Market Value Of The Genomics Services Market Grow Between 2026 And 2030?

The genomics services market has seen swift growth in recent years. It is projected to expand from $18.29 billion in 2025 to $21.56 billion in 2026, registering a compound annual growth rate (CAGR) of 17.9%. This historical growth can be attributed to factors like early adoption by research institutes, the commercialization of sequencing services, increasing biopharma research, the availability of skilled bioinformaticians, and the expansion of laboratory services.

The genomics services market is projected to experience substantial expansion over the upcoming years, reaching a valuation of $37.78 billion by 2030, driven by a compound annual growth rate (CAGR) of 15.0%. This anticipated growth during the forecast period is fueled by factors such as the integration of genomic services into standard clinical care, increasing demand for preventive genomics, the expansion of companion diagnostics, the integration of digital health solutions, and the proliferation of genomics startups. Key trends anticipated within this period encompass a rising demand for sequencing and interpretation services, the broadening of personalized genomic health services, an uptick in the outsourcing of genomic analysis, the increasing uptake of clinical genomics services, and the development of population-scale genomics projects.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/genomics-services-global-market-report

What Leading Drivers Are Supporting The Genomics Services Market Expansion?

The increasing demand for gene therapy is set to drive the expansion of the genomics services market. Gene therapy, a medical strategy designed to treat or prevent diseases by addressing underlying genetic issues, offers targeted treatments for both genetic and chronic conditions. Within gene therapy, genomic services are indispensable for precise tissue targeting, accurate quantification and characterization of viral vectors, and evaluating the risk of shedding. A notable example from April 2024 highlights this trend: the U.S. Food and Drug Administration (FDA) reported that over 80% of rare diseases possess a known genetic basis, with the FDA having approved 22 gene therapy products, predominantly for rare disorders. Consequently, the escalating need for gene therapy is a key factor propelling the growth of the genomics services market.

Which Segments Define The Genomics Services Market Segment Structure?

The genomics services market covered in this report is segmented –

1) By Product: Instruments Or Systems Or Software, Consumables And Reagents

2) By Services Type: Gene Expression Services (RNASeq), Epigenomics Services, Genotyping, Next-Generation Sequencing, Sanger Sequencing, Other Service Types

3) By End-User: Research Institutes, Healthcare Facilities And Diagnostic Centers, Pharmaceutical And Biotechnological Companies, Contract Research Organizations (CROs), Other End Users

Subsegments:

1) By Instruments Or Systems Or Software: Sequencing Instruments and Platforms, Bioinformatics and Genomic Data Analysis Software

2) By Consumables And Reagents: Library Preparation Kits and Sample Preparation Reagents, Sequencing Reagents and Flow Cells

What Emerging Trends Are Seen In The Genomics Services Market?

Leading companies in the genomics services market are concentrating on expanding their offerings by incorporating sophisticated services, such as advanced long-read sequencing services, to address the growing need for comprehensive genomic analysis and personalized medicine. These advanced long-read sequencing services employ cutting-edge technologies to analyze genetic material using extended sequence reads, facilitating a more thorough and accurate characterization of DNA and RNA. For instance, in April 2024, Clinical-Microbiomics A/S, a Denmark-based biotechnology company, launched advanced long-read sequencing services, which include 16S, ITS, 18S rRNA, isolate, and metagenomics sequencing services. These offerings are specifically designed to meet the rigorous requirements of academic, clinical, and industrial researchers, delivering exceptional resolution and quality in microbial analysis. The enhanced long-read sequencing capabilities, which encompass a broad array of sequencing options, aim to redefine the standards of microbial analysis and microbiome research. These developments signify a major progression in microbiome research, providing researchers with in-depth insights into microbial communities and fostering significant discoveries in the field.

Who Are The Established Players Within The Genomics Services Market?

Major companies operating in the genomics services market are Thermo Fisher Scientific Inc., Danaher Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., QIAGEN Inc., LGC Limited, Myriad Genetics Inc., Q2 Solutions Inc., BGI Genomics Inc., 10x Genomics Inc., Invitae Corporation, Fulgent Genetics Inc., 23andMe Inc., Oxford Nanopore Technologies plc, Color Genomics Inc., GENEWIZ Inc., Foundation Medicine Inc., Pacific Biosciences Inc., Avance Biosciences Inc., Macrogen Inc

Get The Full Genomics Services Market Report:

https://www.thebusinessresearchcompany.com/report/genomics-services-global-market-report

Which Geographic Region Dominates The Genomics Services Market?

North America was the largest region in the genomics services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomics services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Genomics Services Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/genomics-services-global-market-report

Browse Through More Reports Similar to the Global Genomics Services Market 2026, By The Business Research Company

Genetic Testing Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-testing-services-global-market-report

Bioinformatics Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/bioinformatics-services-global-market-report

Genomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Genomics Services Market By 2030 Starting From Its 2026 Size?

The genomics services market size has witnessed rapid growth in recent years. This market is expected to expand from $18.29 billion in 2025 to $21.56 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 17.9%. The historical growth of the market can be attributed to factors such as early adoption by research institutes, the commercialization of sequencing services, an increase in biopharma research, the availability of skilled bioinformaticians, and the expansion of laboratory services.

The size of the genomics services market is projected to experience substantial expansion over the coming years. It is anticipated to reach $37.78 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.0%. Key drivers for this growth during the forecast period include its integration into routine clinical care, the increasing demand for preventive genomics, the expansion of companion diagnostics, the integration of digital health solutions, and the proliferation of genomics startups. Significant trends expected in the forecast timeframe encompass a rising demand for sequencing and interpretation services, the broadening of personalized genomic health services, an uptick in the outsourcing of genomic analysis, the greater adoption of clinical genomics services, and the development of population-scale genomics projects.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15576&type=smp

What Drivers Are Shaping The Future Growth Of The Genomics Services Market?

The increasing demand for gene therapy is anticipated to boost the growth of the genomics services market moving forward. Gene therapy is a medical approach used to treat or prevent diseases by addressing the fundamental genetic issue. It delivers targeted treatments for genetic disorders and chronic diseases by resolving their underlying genetic causes. Genomic services play a role in gene therapy for targeting the correct tissue, quantifying and characterizing viral vectors, and understanding the risk of shedding. For instance, in April 2024, according to U.S. The Food and Drug Administration (FDA), a US-based government regulatory agency, reported that over 80% of rare diseases have a known genetic basis. The FDA has approved 22 gene therapy products, with most being for rare disorders. Therefore, the growing demand for gene therapy is propelling the expansion of the genomics services market.

Which Segment Categories Define The Genomics Services Market?

The genomics services market covered in this report is segmented –

1) By Product: Instruments Or Systems Or Software, Consumables And Reagents

2) By Services Type: Gene Expression Services (RNASeq), Epigenomics Services, Genotyping, Next-Generation Sequencing, Sanger Sequencing, Other Service Types

3) By End-User: Research Institutes, Healthcare Facilities And Diagnostic Centers, Pharmaceutical And Biotechnological Companies, Contract Research Organizations (CROs), Other End Users

Subsegments:

1) By Instruments Or Systems Or Software: Sequencing Instruments and Platforms, Bioinformatics and Genomic Data Analysis Software

2) By Consumables And Reagents: Library Preparation Kits and Sample Preparation Reagents, Sequencing Reagents and Flow Cells

What Key Developments And Trends Are Impacting The Genomics Services Market?

Key players within the genomics services market are concentrating on broadening their service offerings to include sophisticated solutions like advanced long-read sequencing services, driven by the growing need for extensive genomic analysis and tailored medical treatments. These advanced long-read sequencing services leverage state-of-the-art technologies for examining genetic material, utilizing longer sequence reads to enable a more exhaustive and precise characterization of both DNA and RNA. An illustrative example is seen in April 2024, when Clinical-Microbiomics A/S, a biotechnology firm based in Denmark, introduced advanced long-read sequencing services encompassing 16S, ITS, 18S rRNA, isolate, and metagenomics sequencing services. Designed to fulfill the exacting demands of academic, clinical, and industrial researchers, these offerings deliver unmatched resolution and superior quality in microbial analysis. These improved long-read sequencing capabilities, which cover a broad spectrum of sequencing choices, aspire to elevate the benchmarks for microbial analysis and microbiome research. Such progress represents a crucial advancement in microbiome research, equipping investigators with granular understanding of microbial communities and fostering pioneering discoveries in this domain.

Who Are The Top Companies Competing In The Genomics Services Market?

Major companies operating in the genomics services market are Thermo Fisher Scientific Inc., Danaher Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., QIAGEN Inc., LGC Limited, Myriad Genetics Inc., Q2 Solutions Inc., BGI Genomics Inc., 10x Genomics Inc., Invitae Corporation, Fulgent Genetics Inc., 23andMe Inc., Oxford Nanopore Technologies plc, Color Genomics Inc., GENEWIZ Inc., Foundation Medicine Inc., Pacific Biosciences Inc., Avance Biosciences Inc., Macrogen Inc

Read the full genomics services market report here:

https://www.thebusinessresearchcompany.com/report/genomics-services-global-market-report

Which Geographic Regions Are Influencing Demand In The Genomics Services Market?

North America was the largest region in the genomics services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomics services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Genomics Services Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15576&type=smp

Browse Through More Reports Similar to the Global Genomics Services Market 2026, By The Business Research Company

Genomics Services Global Market Report

https://www.thebusinessresearchcompany.com/report/genomics-services-global-market-report

Ai In Genomics Global Market Report

https://www.thebusinessresearchcompany.com/report/ai-in-genomics-global-market-report

Genomic Data Analysis And Interpretation Global Market Report

https://www.thebusinessresearchcompany.com/report/genomic-data-analysis-and-interpretation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model